Stocks and Investing Stocks and Investing
Thu, August 3, 2023

Andrew Fein Reiterated (BPMC) at Strong Buy and Held Target at $85 on, Aug 3rd, 2023


Published on 2024-10-28 05:26:21 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Blueprint Medicines Corporation" (BPMC) at Strong Buy and Held Target at $85 on, Aug 3rd, 2023.

Andrew has made no other calls on BPMC in the last 4 months.



There are 6 other peers that have a rating on BPMC. Out of the 6 peers that are also analyzing BPMC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $46 on, Tuesday, May 23rd, 2023


These are the ratings of the 5 analyists that currently disagree with Andrew


  • Derek Archila of "Wells Fargo" Upgraded from Hold to Buy and Increased Target to $83 on, Monday, July 31st, 2023
  • Andrew Berens of "SVB Leerink" Downgraded from Hold to Sell and Decreased Target to $43 on, Monday, June 5th, 2023
  • Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $75 on, Tuesday, May 23rd, 2023
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $82 on, Tuesday, May 23rd, 2023
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $114 on, Tuesday, May 23rd, 2023
Contributing Sources